Diabetic polyneuropathy not up with impaired glycemia

March 3, 2012
Diabetic polyneuropathy not up with impaired glycemia

(HealthDay) -- Although significantly increased in subjects with new diabetes, the rates of typical diabetic polyneuropathy (DPN), retinopathy, and nephropathy are not significantly different between subjects with and without impaired glycemia (IG), according to research published in the March issue of Diabetes Care.

Peter J. Dyck, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues conducted a prospective, population-based survey of 150 subjects without IG, 174 with IG, and 218 with new diabetes to determine whether DPN, retinopathy, or nephropathy are more prevalent in subjects with IG than in healthy subjects.

The researchers found that the frequency of retinopathy and nephropathy was not significantly different between patients with and without IG, but was greater in those with new diabetes. The frequency of narrowly defined DPN was 2, 1.7, and 7.8 percent in non-IG, IG, and new diabetes subjects, respectively. Using a broader definition, the frequency of DPN was 12.7, 12.6, and 17.4 percent in non-IG, IG, and new diabetes subjects, respectively.

"Prevalence of typical DPN, , and nephropathy was significantly increased only in subjects with new diabetes," the authors write. "For atypical DPN, such an increase was not observed even in subjects with new diabetes. In , explanations other than IG should be sought for patients with atypical DPN (chronic idiopathic axonal polyneuropathy) who have IG."

Explore further: Prediabetes may not explain diabetic polyneuropathies

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Prediabetes may not explain diabetic polyneuropathies

February 22, 2012

In a reversal of two decades of medical reports, a Mayo Clinic study finds the frequency of nerve damage called diabetic polyneuropathy is similar in prediabetic patients and healthy people. Physicians should seek explanations ...

Let's stretch... Scientists study myomesin protein

February 14, 2012

The proteins actin, myosin and titin are big players in the business of muscle contraction. Scientists at the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now examined another muscle protein – ...

Recommended for you

How does friendly fire happen in the pancreas?

October 21, 2016

In type 1 diabetes, the body attacks its own insulin-producing cells. Scientists at Helmholtz Zentrum München, partner in the German Center for Diabetes Research, and their colleagues at Technical University of Munich have ...

Diabetes opens floodgates to fructose

October 11, 2016

Fructose, once seen as diabetics' alternative to glucose, is fast-tracked to the liver in diabetic mice and contributes to metabolic diseases, according to new research from Harvard University.

Type 2 diabetes and obesity—what do we really know?

October 6, 2016

Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world. In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.